A group of US lawmakers is pressuring the Trump administration to block American companies from purchasing memory chips made by ChangXin Memory Technologies, a Chinese semiconductor manufacturer that the Pentagon identified as a Chinese military company in 2025.

The push comes as Apple has been quietly lobbying the administration since around May 2026 for clearance to buy CXMT’s DRAM chips, a move that has turned what might have been a routine supply chain decision into a full-blown national security debate.

Apple’s CXMT gamble

Apple has reportedly been testing CXMT chips for devices destined for the Chinese market. CXMT has been gaining ground fast, growing its global DRAM market share from 3% to 8% in Q1 2026. Rep. John Moolenaar has made clear that sourcing components from a firm linked to the Chinese military is, in his view, a serious mistake that ultimately strengthens China.

The concern isn’t just about where Apple buys its chips. It’s about the downstream effects: revenue flowing to a company the Pentagon considers military-adjacent, and the potential for that money to fuel China’s artificial intelligence and defense capabilities.

The Entity List standoff

Multiple US agencies reportedly approved adding the company to the Commerce Department’s Entity List last year. That list is essentially the government’s do-not-sell-to registry, and landing on it would impose severe restrictions on CXMT’s ability to do business with American firms.

But the Trump administration has delayed pulling the trigger. The reasoning, according to the research, is straightforward: the administration doesn’t want to further strain relations with Beijing at a time when US-China tensions are already running hot on multiple fronts.

CXMT’s rise and the DRAM market

The company is also reportedly pursuing an IPO on the Shanghai exchange, targeting approximately $9.8 billion in proceeds. A listing of that size would rank among the largest Chinese tech IPOs in recent memory and would give CXMT a war chest to invest in next-generation manufacturing capacity.

The global DRAM market is dominated by three players: Samsung, SK Hynix, and Micron. CXMT carving out an 8% share means it’s no longer a rounding error. Its growth has come largely through aggressive pricing that undercuts established players.

What this means for investors

For Apple specifically, the outcome of this lobbying effort matters for margin management. If the company can’t access cheaper Chinese DRAM, it faces higher input costs at a time when AI-driven memory demand is already pushing prices up.

For the broader semiconductor sector, companies like Micron could benefit if US firms are effectively barred from buying CXMT products, since demand would shift toward non-Chinese suppliers. The CXMT IPO is another variable worth watching. A successful $9.8 billion listing would potentially attract institutional capital that further accelerates its expansion, creating a competitive threat that could pressure margins across the DRAM industry for investors in Samsung, SK Hynix, and Micron.